Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Cytopathology, slides, cervical or vaginal (the Bethesda System); with manual screening and computer-assisted rescreening under physician supervision

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 88166 refers to a specific cytopathology procedure involving the analysis of cervical or vaginal slides using the Bethesda System. Commonly known as a Papanicolaou (PAP) smear, this test is a critical screening tool for detecting cervical cancer and other abnormalities in cervical cells. The Bethesda System is the standard reporting framework utilized in the United States for interpreting PAP smear results. It provides a comprehensive assessment of the adequacy of the sample collected, identifies any signs of infection, and categorizes cellular changes. These changes may include benign alterations, atypical squamous cells of undetermined significance (ASCUS), atypical glandular cells of undetermined significance (AGCUS), and various degrees of dysplasia or squamous intraepithelial lesions (SIL), which are further classified into low-grade (LGSIL) and high-grade (HGSIL) lesions, as well as carcinoma. During the procedure, cells are collected from the endocervix using a specialized stick or brush, and the specimen is then smeared onto a glass slide. The slide is fixed using either a spray or immersion method and subsequently covered with a coverslip. Once prepared, the slide is sent to a cytology laboratory for staining. A trained technician screens the slide under a microscope to identify any abnormalities, focusing on abnormal cells or clusters that may indicate potential issues. The process may involve multiple screenings, including manual and computer-assisted methods, to ensure thorough evaluation. The findings from the screening are communicated to the treating physician, and if any abnormalities are detected, further diagnostic procedures may be recommended.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The CPT® Code 88166 is indicated for the following conditions and symptoms:

  • Cervical Cancer Screening This procedure is primarily performed as a routine screening for cervical cancer in women.
  • Detection of Abnormalities It is used to identify any abnormal cellular changes in the cervical or vaginal area that may indicate precancerous conditions or cancer.
  • Monitoring of Previous Abnormal Results The test is indicated for patients who have had previous abnormal PAP smear results and require follow-up screening.
  • Assessment of Infections It can also help in detecting infections that may affect cervical health.

2. Procedure

The procedure for CPT® Code 88166 involves several detailed steps to ensure accurate cytopathological evaluation:

  • Step 1: Sample Collection Cells are collected from the endocervix using a specialized stick or brush designed for this purpose. This step is crucial as it ensures that an adequate sample is obtained for analysis.
  • Step 2: Slide Preparation The collected specimen is smeared onto a glass slide. The slide is then fixed using either a spray or immersion technique to preserve the cellular structure for examination.
  • Step 3: Staining After preparation, the slide is sent to a cytology laboratory where it undergoes staining. This process enhances the visibility of the cells under a microscope, allowing for better identification of abnormalities.
  • Step 4: Manual Screening A trained technician manually screens the stained slide under a microscope. This initial screening focuses on identifying any abnormal cells or cell clusters that may indicate potential issues.
  • Step 5: Manual Rescreening Following the initial screening, a manual rescreening is performed. This involves a complete reassessment of the entire slide, which may be conducted by a second technician to ensure thorough evaluation and accuracy.
  • Step 6: Interpretation of Findings The technician reviews the findings from both the initial and rescreening processes. Any identified abnormalities are carefully documented, and the results are communicated to the treating physician for further action.

3. Post-Procedure

After the procedure associated with CPT® Code 88166, the following post-procedure care and considerations are typically observed:

The findings from the PAP smear are communicated to the treating physician, who will review the results. If any abnormalities are detected, the pathologist may recommend additional follow-up procedures, such as a repeat PAP smear at a shorter interval than usual, colposcopy, endocervical curettage, or biopsy to further investigate the findings. Patients may be advised on the importance of regular screenings and follow-up appointments to monitor their cervical health. It is essential for patients to discuss any concerns or symptoms with their healthcare provider to ensure appropriate management and care.

Short Descr CYTOPATH TBS C/V AUTO REDO
Medium Descr CYTP SLIDES C/V MNL SCR&CPTR RESCR PHYS SUPV
Long Descr Cytopathology, slides, cervical or vaginal (the Bethesda System); with manual screening and computer-assisted rescreening under physician supervision
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 234 - Pathology

This is a primary code that can be used with these additional add-on codes.

88155 Female Edit Addon Code MPFS Status: Statutory exclusion (from MPFS, may be paid under other methodologies) APC Q4 PUB 100 CPT Assistant Article Cytopathology, slides, cervical or vaginal, definitive hormonal evaluation (eg, maturation index, karyopyknotic index, estrogenic index) (List separately in addition to code[s] for other technical and interpretation services)
Date
Action
Notes
2011-01-01 Changed Short description changed.
1999-01-01 Added First appearance in code book in 1999.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"